These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26806581)

  • 21. [Role of coronary artery revascularization and aneurysmectomy in ventricular arrhythmias in the chronic phase of myocardial infarction].
    Felices Nieto A; Pavón García M; Barquero Aroca JM; Infantes Alcón C; Nieto Gutiérrez P; Ruiz Navas F; Cruz Fernández JM
    Rev Esp Cardiol; 2002 Oct; 55(10):1052-6. PubMed ID: 12383390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catheter Ablation of Ventricular Tachycardia as the First-Line Therapy in Patients With Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long-Term Results.
    Clemens M; Peichl P; Wichterle D; Pavlů L; Čihák R; Aldhoon B; Kautzner J
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1105-10. PubMed ID: 26179108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.
    Katritsis DG; Siontis KC; Bigger JT; Kadish AH; Steinman R; Zareba W; Siontis GC; Bardy GH; Ioannidis JP
    Heart Rhythm; 2013 Feb; 10(2):200-6. PubMed ID: 23107652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
    Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Di Marco A; Anguera I; Nombela-Franco L; Oloriz T; Teruel L; Rodriguez Mañero M; Toquero J; León V; Dallaglio P; Perez Guerrero A; Salazar CH; Escaned J; Asso Abadía A; Gomez Hospital JA; Cequier A
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E1-E11. PubMed ID: 32460428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.
    Freixa X; Chan J; Bonan R; Ibrahim R; Lamarche Y; Demers P; Basmadjian A; Ibrahim R; Cartier R; Asgar AW
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):450-8. PubMed ID: 25115215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.
    Waks JW; Buxton AE
    Annu Rev Med; 2018 Jan; 69():147-164. PubMed ID: 29414264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of ventricular arrhythmias in patients with left ventricular enlargement and moderate left ventricular dysfunction.
    Zhao S; Chen K; Su Y; Hua W; Yang J; Chen S; Liang Z; Xu W; Zhang S
    Clin Cardiol; 2016 Dec; 39(12):703-708. PubMed ID: 27610940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
    Powell AC; Fuchs T; Finkelstein DM; Garan H; Cannom DS; McGovern BA; Kelly E; Vlahakes GJ; Torchiana DF; Ruskin JN
    Circulation; 1993 Sep; 88(3):1083-92. PubMed ID: 8353870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of Risk of Ventricular Arrhythmias After Improvement in Left Ventricular Ejection Fraction During Follow-Up in Patients With Primary Prevention Implantable Cardioverter Defibrillators.
    Smer A; Saurav A; Azzouz MS; Salih M; Ayan M; Abuzaid A; Akinapelli A; Kanmanthareddy A; Rosenfeld LE; Merchant FM; Abuissa H
    Am J Cardiol; 2017 Jul; 120(2):279-286. PubMed ID: 28532779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial.
    Garzillo CL; Hueb W; Gersh BJ; Lima EG; Rezende PC; Hueb AC; Vieira RD; Favarato D; Pereira AC; Soares PR; Serrano CV; Ramires JA; Kalil Filho R
    Eur Heart J; 2013 Nov; 34(43):3370-7. PubMed ID: 23828828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart rate turbulence.
    Cygankiewicz I
    Prog Cardiovasc Dis; 2013; 56(2):160-71. PubMed ID: 24215748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Liang JJ; Fender EA; Cha YM; Lennon RJ; Prasad A; Barsness GW
    Am J Cardiol; 2016 Mar; 117(5):709-13. PubMed ID: 26796195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation.
    Fan X; Hua W; Xu Y; Ding L; Niu H; Chen K; Xu B; Zhang S
    Heart; 2014 Aug; 100(16):1242-9. PubMed ID: 24895352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.